Company intelligence / Profile preview

Biofourmis

Boston, Massachusetts, United Statesbiofourmis.com ↗

Ownership: Private
Employees: ~350
Development stage: Commercial

Overview

Biofourmis has demonstrated significant improvements in healthcare delivery through its technology-enabled solutions. Outcomes include up to a 70% reduction in hospital readmissions, earlier detection of patient deterioration by an average of 21 hours, and cost reductions up to 38%. The company’s platforms have been validated in peer-reviewed studies for remote patient management and are used by leading health systems worldwide.

Therapeutic areas: OncologyPulmonologyCardiovascularNeurologyInfectious Diseases
Modalities: Digital therapeutics/software-based therapeuticsRemote patient monitoring (RPM)AI-driven health analyticsWearable biosensors
Industry: Digital Health Medical Devices

Partnerships

Biofourmis has secured agreements with top‑20 pharmaceutical companies for digital clinical trials and biomarker platformscollaborates with over 50+ health systems/payers worldwide, including AdventHealth and Lee Healthworks closely with biopharma partners on trial modernization.

Beyond the preview

Go deeper on Biofourmis.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biofourmis.

Explore the full profile